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Hereditary Hemochromatosis is an autosomal recessive disorder characterized by excessive intestinal iron absorption and pathological iron deposition in organs such as liver, 
heart and pancreas. The disease is predominantly caused by homozygosity for the p.C282Y mutation in HFE, which impairs protein association with its chaperone beta-2 
microglobulin (B2M) for correct folding and traffic to the cell surface.1  
The role of full length HFE on iron homeostasis remains unclear. It has been postulated  that it may contribute to iron metabolism regulation by acting in hepatocytes, activating 
hepcidin synthesis and in duodenum, regulating the expression of iron metabolism related genes, thus preventing iron overload. 
HFE transcripts are widely expressed and the predominant (full length) mRNA identified has ≈4.2 kb in length. In addition, several alternative splicing HFE transcripts have been 
reported but their functional significance remains elusive. 1,2,3  
Since we have identified a novel alternative HFE transcript due to the intron 4 inclusion4 (Fig. 1), we aimed to investigate its tissue-specific expression level, the corresponding 
protein structure and cellular location, as well as its putative physiological function at duodenal level. 
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s  RT-qPCRs using RNAs from 8 human tissues were performed to quantify the HFE intron 4 inclusion 
splicing transcript as well as the total amount of HFE transcripts. 
 HFE cDNA was tagged to the GFP gene in the pEGFP-N1 vector. The hepatocarcinoma cell line 
HepG2 was transfected with the full length or the intron 4 inclusion construct, in order to obtain the 
corresponding GFP-tagged protein variants. Protein cellular localization was detected by 
immunofluorescence assays raising antibodies against B2M, Calnexin (an endoplasmic reticulum 
marker; ER) and Transferrin Receptor 1 (TfR1). 
 HuTu-80 cells (human duodenum adenocarcinoma) were transfected with pcDNA3 constructs 
expressing HFE_full length (HFE) and HFE_ivs4 (sHFE) tagged to Flag, followed by an iron stimulus 
(holo-transferrin 20µM; holo). Cell lysates and cell culture supernatants were submitted to 
immunoprecipitation assays using mouse anti-Flag antibody. These were subjected to a 12% SDS-
PAGE, followed by transfer to a nitrocellulose membrane. Immunodetections were performed with 
mouse antibody anti-Flag, mouse anti-TfR1 and rabbit anti-B2M.  
RNA was extracted from these cells and the expression of iron-related genes TFR1, DMT1, B2M, 
SLC40A1, CYBRD1 and HEPH were assessed by RT-qPCR.  
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1) HFE_intron 4 inclusion transcript 
expression in different human tissues   
 
RT-qPCR 
                                            2) HFE_ivs4 protein variant cellular co-localization in hepatic cells                      
  
 Immunofluorescence (HepG2)  
 3) HFE_ivs4 protein variant cellular traffic 
 
                                                                                                                   Immunoprecipitation (HuTu-80) 
4) Effect of  the sHFE variant in iron-metabolism related genes expression in a duodenal cell line 
(HuTu-80) 
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Fig. 1. HFE full length and intron 4 inclusion transcripts.  
A premature stop codon  exists in the alternative splicing transcript. 
 Here we show a soluble isoform of the HFE protein (sHFE), resulting from a HFE 
alternative splicing transcript  including the intron 4. Due to the presence of  a premature 
termination codon within this intron, it originates a truncated protein which lacks the 
transmembrane and cytoplasmic domains. However, it seems to be  correctly processed, 
since it surpasses the ER barrier and is secreted to the cell supernatant in association with 
B2M. 
 The over expression of the sHFE in a duodenal cell line is able to modify de expression of 
some iron metabolism related genes . We found that it acts by repressing the expression of 
the duodenal cytochrome b and hephastin, independently of the iron status, as it happens 
with the full-length HFE. Since those are proteins presenting well known functions in iron 
absorption, we can hypothesize that their decrease expression modulated by the sHFE will 
be translated to a reduction of dietary iron absorption in the duodenum. 
 Through this study we might have unveiled the contribution of the sHFE splice variant to 
iron homeostasis. In fact, sHFE may be secreted by several tissues into the bloodstream 
and may act in the regulation of dietary iron absorption in duodenum, reducing dietary 
iron absorption, preventing iron overload and contributing to iron metabolism regulation.  
 HFE_intron 4 inclusion transcript 
has an ubiquitous expression, being 
its relative expression higher in 
duodenum and testis and lower in 
liver. 
 The HFE_full length protein co-localizes with 
B2M and TfR1, mostly at cell surface but not 
with calnexin (ER marker).  
 HFE_ivs4 protein does not localize with TfR1 
or with calnexin. 
 Both HFE_full length and HFE_ivs4 proteins are associated with B2M in cell lysates, however, only 
HFE_full length protein is found associated with TfR1 in the cell lysates without holo-Tf stimulus. 
The HFE_ivs4 protein is a truncated soluble HFE protein variant (sHFE) that is secreted by cells 
maintaining its interaction with B2M. 
 As expected, TFR1 expression is 
inhibited by holo-Tf. 
 The over expression of HFE_full length 
(HFE) and HFE_ivs4 (sHFE) seem to 
slightly increase the expression of TfR1. 
 DMT1 does not vary with HFE or sHFE 
over expression. 
 The expression of both B2M and 
SLC40A1 (genes coding for B2M and 
ferroportin-1 proteins) seems to be 
slightly down-regulated by HFE and iron 
stimulus, respectively. 
 CYBRD1 (duodenal cytochrome b) 
expression is reduced in about 20% 
after over expression of both HFE and 
sHFE, independently of iron stimulus. 
 HEPH (hephaestin) expression is 
highly down regulated by HFE and 
sHFE, independently of iron status. 
Bar represents 10 µm 
NT – not transfected 
Standard deviations are a representation of three independent experiments 
p-values were calculated by the bicaudal student’s t-test 
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